Comparison of removal efficacy of blood nucleic acids, phenol derivatives, xanthine derivatives and the mitochondrial functional marker in hemodialysis and online hemodiafiltration

Comparison of removal efficacy of blood nucleic acids, phenol derivatives, xanthine derivatives and the mitochondrial functional marker in hemodialysis and online hemodiafiltration - Comparison of removal efficacy of blood nucleic acids, phenol derivatives, xanthine derivatives and the mitochondrial functional marker in hemodialysis and online hemodiafiltration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030669

Enrollment

Registered

2018-01-14

Start date

2018-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis

Interventions

We change the dialysis method such as the hemodialysis, the pre-dilution hemodiafiltration and the post-dilution hemodiafiltration.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable chronic maintenance dialysis patients.

Exclusion criteria

Exclusion criteria: The patient who uses blood purification except for hemodialysis or hemodiafiltration together.

Design outcomes

Primary

Measure	Time frame
The reduction ratio and total solute removal of blood nucleic acids (1-Methyladenosine, etc) and phenol derivatives (indoxylsulphate, p-cresylsulphate, etc) in hemodialysis and online hemodiafiltration.	—

Countries

Japan

Contacts

Public ContactHisato Shima

Kawashima hospital Department of Kidney Disease

h.shima@khg.or.jp088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026